Product
CoronaVac®
3 clinical trials
2 indications
Indication
COVID-19Indication
VaccinesClinical trial
Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine (RBMRNA-405) as a Booster in Chinese Adults & OlderStatus: Completed, Estimated PCD: 2022-06-13
Clinical trial
A Randomized, Blinded, Parallel-controlled Phase 3 Study to Evaluate the Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccine (LVRNA009) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated 2 Doses Inactivated SARS-CoV-2 VaccineStatus: Not yet recruiting, Estimated PCD: 2023-10-01